Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials

British Journal of Haematology

Volumn 99, Issue 4, 1997, Pages 925-928

  Langabeer, S E ^a   Walker, H ^a   Rogers, J R ^a   Burnett, A K ^b   Wheatley, K ^c   Swirsky, D ^d   Goldstone, A H ^a   Linch, D C ^a,d  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AML; AML1 ETO; Prognosis; t(8; 21)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CYTOGENETICS; GENE FUSION; HUMAN; INCIDENCE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031456023     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4663270.x     Document Type: Article

References (12)

1. Andrieu, V., Radford-Weiss, I., Troussard, X., Chane, C., Valensi, F., Guesnu, M., Haddad, E., Viguier, F., Dreyfus, F., Varet, B., Flandrin, G. & Macintyre, E. (1996) Molecular detection of the t(8;21)/ AML1-ETO in AML M1/M2: correlation with cytogenetics. morphology and immunophenotype. British Journal of Haematology, 92, 855-865.
2. Chang, K-S., Fan, Y.H., Stass, S.A., Estey, E.H., Wang, G., Trujillo, J.M., Erickson, P. & Drabkin, H. (1993) Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene, 8, 983-988.
3. Erickson, P., Gao, J., Chang, K-S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. & Drabkin, H. (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript. AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood, 80, 1825-1831.
4. Grimwade, D., Walker, H., Harrison, C., Oliver, F., Wheatley, K., Harrison, G., Gray, R., Hann, I., Stevens, R., Rees, J., Goldstone, A. & Burnett, A. (1996) Impact of diagnostic cytogenetics on outcome in AML: analysis of 1613 patients entered into the UK MRC AML 10 trial. Blood, 88, (Suppl. 1), 2525a.
5. Heim, S. & Mitelman, F. (1995) Acute myeloid leukemia. Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. Wiley-Liss, New York.
6. Kusec, R., Laczika, K., Knobl, P., Friedl, J., Greinix, H., Kahls, P., Linkesch, W., Schwarzinger, I., Mitterbauer, G., Purtscher, B., Haas, O.A., Lechner, K. & Jaeger, U. (1994) AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia, 8, 735-739.
7. Langabeer, S.E., Walker, H., Gale, R.E., Wheatley, K., Burnett, A.K., Goldstone, A.H. & Linch, D.C. (1997) Frequency of CBFB/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. British Journal of Haematology, 96, 736-739.
8. Maruyama, F., Yang, P., Stass, S.A., Cork, A., Freireich, E.J., Lee, M-S. & Chang, K-S. (1993) Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia. Cancer Research, 53, 4449-4451.
9. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. & Ohki, M. (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proceedings of the National Academy of Sciences of the United States of America, 88, 10431-10434.
10. Nucifora, G., Dickenstein, J.I., Torbenson, V., Roulston, D., Rowley, J. & Vardiman, J.W. (1994) Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia, 8, 1533-1538.
11. Nucifora, G. & Rowley, J.D. (1995) AML1 and the 8;21 and 3;21 transiocations in acute and chronic myeloid leukemia. Blood, 86, 1-14.
12. Sawyers, C.L. (1997) Molecular genetics of acute leukaemia. Lancet, 349, 196-200.